title: [Serum complement level (C'H5O) during treatment of rheumatoid arthritis patients].
abstract: Decreased total complement serum level (C'H50) was established in 72 per cent of the 78 patients examined, associated most likely with the developing processes of antigen-antibody reaction and the severe course of the illness. The applied treatment with different antirheumatic remedies, according to their mechanism of action, determined the respective changes in the complement level. Indomethacinum and chinoline derivatives induce complement values elevation, whereas the corticosteroids, salicylate and pyrazolone preparations lead to the complement values normalization.
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D003165:Complement System Proteins; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000963:Antimetabolites; D011720:Pyrazoles; D011804:Quinolines; D012459:Salicylates; D003165:Complement System Proteins; D007213:Indomethacin
vernacular_title: Nivo na serumniia komplement (C'H5O) pri lechenie na bolni s revmatoiden artrit